UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 103

Sortiert nach

Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)

Leukemia, 2009-06, Vol.23 (6), p.1152-1157

2009

Volltextzugriff (PDF)

The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function

Annals of oncology, 2012-03, Vol.23 (3), p.722-729

2012

Volltextzugriff (PDF)

Polymicrobial bacterial or fungal infections: incidence, spectrum of infection, risk factors, and clinical outcomes from a large hematopoietic stem cell transplant center

Transplant infectious disease, 2015-04, Vol.17 (2), p.267-274

2015

Volltextzugriff (PDF)

SURVIVAL AMONG A PATIENT COHORT OF RELAPSED/REFRACTORY MYCOSIS FUNGOIDES IN FRANCE, GERMANY, ITALY, SPAIN AND THE UNITED KINGDOM

Hematological oncology, 2019-06, Vol.37 (S2), p.485-486

2019

Volltextzugriff (PDF)

Treatment of Waldenstrom’s Macroglobulinemia With Thalidomide

Journal of clinical oncology, 2001-08, Vol.19 (16), p.3596-3601

2001

Volltextzugriff (PDF)

Amphotericin B deoxycholate nasal spray administered to hematopoietic stem cell recipients with prior fungal colonization of the upper airway passages is associated with low rates of invasive fungal infection

Transplant infectious disease, 2015-02, Vol.17 (1), p.1-6

2015

Volltextzugriff (PDF)

GVL effect in plasmacytoid DC leukemia lymphoma

Bone marrow transplantation (Basingstoke), 2010-05, Vol.45 (5), p.961-962

2010

Volltextzugriff (PDF)

Survival and prognostic factors after initiation of treatment in Waldenstrom’s macroglobulinemia

Annals of oncology, 2003-08, Vol.14 (8), p.1299-1305

2003

Volltextzugriff (PDF)

Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone

Seminars in oncology, 2003-04, Vol.30 (2), p.265-269

2003

Volltextzugriff (PDF)

Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma

The hematology journal : the official journal of the European Haematology Association, 2004, Vol.5 (2), p.112

2004

Volltextzugriff (PDF)

Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent

Bone marrow transplantation (Basingstoke), 2000-06, Vol.25 (12), p.1319-1320

2000

Volltextzugriff (PDF)

887MO Real-world treatment management of patients with advanced-stage classic Hodgkin lymphoma receiving front line therapy

Annals of oncology, 2020-09, Vol.31, p.S649-S650

2020

Volltextzugriff (PDF)

Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b)

Leukemia, 1996-12, Vol.10 (12), p.1966-1970

1996

Volltextzugriff (PDF)

Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemia

British journal of haematology, 1997-03, Vol.96 (3), p.617-619

1997

Volltextzugriff (PDF)

888MO Effectiveness of brentuximab vedotin in relapsed/refractory classic Hodgkin lymphoma: A systematic review and meta-analysis

Annals of oncology, 2020-09, Vol.31, p.S650-S650

2020

Volltextzugriff (PDF)

Primary renal lymphoma presenting with chronic low-grade fever

International journal of hematology, 2004-05, Vol.79 (4), p.361-363

2004

Volltextzugriff (PDF)

Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies

European journal of haematology, 2017-11, Vol.99 (5), p.409-414

2017

Volltextzugriff (PDF)

Contemporary treatment patterns and response in relapse/refractory cutaneous T-cell lymphoma (CTCL) in clinical practice in France, Germany Italy, Spain and the United Kingdom

European journal of cancer (1990), 2019, Vol.119, p.S36

2019

Volltextzugriff (PDF)

098 - Contemporary treatment patterns and response in relapse/refractory cutaneous T-cell lymphoma (CTCL) in clinical practice in France, Germany Italy, Spain and the United Kingdom

European journal of cancer (1990), 2019, Vol.119, p.S36-S36

2019

Volltextzugriff (PDF)

P130 Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience

Leukemia research, 2009-05, Vol.33, p.S134-S135

2009

Volltextzugriff (PDF)

Treatment of Waldenström’s Macroglobulinemia With Rituximab

Journal of clinical oncology, 2002-05, Vol.20 (9), p.2327-2333

2002

Volltextzugriff (PDF)

Treatment of Relapsed/Refractory Multiple Myeloma with Thalidomide-based Regimens: Identification of Prognostic Factors

Leukemia & lymphoma, 2004-11, Vol.45 (11), p.2275-2279

2004

Volltextzugriff (PDF)

Red cell fragmentation (schistocytosis) after bone marrow transplantation

Bone marrow transplantation (Basingstoke), 1998-10, Vol.22 (8), p.777-780

1998

Volltextzugriff (PDF)

Graft-versus-myeloma after donor leukocyte infusion : maintenance of marrow remission but extramedullary relapse with plasmacytomas

Bone marrow transplantation (Basingstoke), 1998-06, Vol.21 (11), p.1163-1165

1998

Volltextzugriff (PDF)

The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens

Haematologica (Roma), 2008-09, Vol.93 (9), p.1420-1422

2008

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(51)
Life Sciences & Biomedicine
(51)
Science & Technology
(51)
Male
(39)
Hematology
(38)
Middle Aged
(36)
Female
(33)
Oncology
(28)
Adult
(27)
Aged
(27)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Aged, 80 And Over
(19)
Prognosis
(13)
Chemotherapy
(12)
Treatment Outcome
(12)
Antineoplastic Agents
(10)
Hematologic And Hematopoietic Diseases
(10)
Transplantation
(10)
Waldenstrom Macroglobulinemia - Drug Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)

The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function

Polymicrobial bacterial or fungal infections: incidence, spectrum of infection, risk factors, and clinical outcomes from a large hematopoietic stem cell transplant center

SURVIVAL AMONG A PATIENT COHORT OF RELAPSED/REFRACTORY MYCOSIS FUNGOIDES IN FRANCE, GERMANY, ITALY, SPAIN AND THE UNITED KINGDOM

Treatment of Waldenstrom’s Macroglobulinemia With Thalidomide

Amphotericin B deoxycholate nasal spray administered to hematopoietic stem cell recipients with prior fungal colonization of the upper airway passages is associated with low rates of invasive fungal infection

GVL effect in plasmacytoid DC leukemia lymphoma

Survival and prognostic factors after initiation of treatment in Waldenstrom’s macroglobulinemia

Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone

Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma

Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent

887MO Real-world treatment management of patients with advanced-stage classic Hodgkin lymphoma receiving front line therapy

Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b)

Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemia

888MO Effectiveness of brentuximab vedotin in relapsed/refractory classic Hodgkin lymphoma: A systematic review and meta-analysis

Primary renal lymphoma presenting with chronic low-grade fever

Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies

Contemporary treatment patterns and response in relapse/refractory cutaneous T-cell lymphoma (CTCL) in clinical practice in France, Germany Italy, Spain and the United Kingdom

098 - Contemporary treatment patterns and response in relapse/refractory cutaneous T-cell lymphoma (CTCL) in clinical practice in France, Germany Italy, Spain and the United Kingdom

P130 Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience

Treatment of Waldenström’s Macroglobulinemia With Rituximab

Treatment of Relapsed/Refractory Multiple Myeloma with Thalidomide-based Regimens: Identification of Prognostic Factors

Red cell fragmentation (schistocytosis) after bone marrow transplantation

Graft-versus-myeloma after donor leukocyte infusion : maintenance of marrow remission but extramedullary relapse with plasmacytomas

The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens

Suchergebnisse filtern